Drug intelligence / Profile preview

Li-Qi Run-Chang granule

Development stage: Preclinical
Lead developer: The First Affiliated Hospital of Guangdong Pharmaceutical University
Administration: Oral

Overview

Li-Qi Run-Chang granule is a Traditional Chinese Medicine (TCM) herbal formulation developed for the treatment of functional constipation. The name reflects its primary therapeutic principles in TCM: "Li-Qi" (regulating Qi to alleviate stagnation) and "Run-Chang" (moistening the intestines to facilitate bowel movements). It is currently being evaluated in clinical trials, such as those sponsored by The First Affiliated Hospital of Guangdong Pharmaceutical University, comparing its efficacy and safety against standard treatments like lactulose. The formulation typically consists of multiple botanical extracts intended to improve gastrointestinal motility and stool consistency.

Other names: Liqi Runchang granule

Beyond the preview

Go deeper on Li-Qi Run-Chang granule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Li-Qi Run-Chang granule.

Explore the full profile